47 min listen
Episode 2: We Don't Talk About Rylaze
ratings:
Length:
45 minutes
Released:
Mar 18, 2022
Format:
Podcast episode
Description
Bernie Marini and Anthony Perissinotti discuss asparaginase, the data (or lack thereof) behind the FDA approval of Rylaze (Erwinia asparaginase), and concerning trends regarding switches between asparaginase products in clinical practice!
Released:
Mar 18, 2022
Format:
Podcast episode
Titles in the series (25)
Episode 3.1: History of Acute Lymphoblastic Leukemia Treatment and Building the BFM Backbone by WolverHeme Happy Hour